Takeda Pharmaceutical (TAK) Competitors

Sanofi (NASDAQ:SNY) and Takeda Pharmaceutical (NYSE:TAK) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Do analysts rate SNY or TAK?

Sanofi currently has a consensus price target of $62.00, suggesting a potential upside of 24.57%. Given Sanofi's stronger consensus rating and higher probable upside, analysts clearly believe Sanofi is more favorable than Takeda Pharmaceutical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanofi	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	3 Strong Buy rating(s)	3.11
Takeda Pharmaceutical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has more risk and volatility, SNY or TAK?

Sanofi has a beta of 0.48, indicating that its stock price is 52% less volatile than the S&P 500. Comparatively, Takeda Pharmaceutical has a beta of 0.22, indicating that its stock price is 78% less volatile than the S&P 500.

Which has preferable earnings & valuation, SNY or TAK?

Sanofi has higher revenue and earnings than Takeda Pharmaceutical. Sanofi is trading at a lower price-to-earnings ratio than Takeda Pharmaceutical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanofi	$44.46B	2.75	$6.02B	$4.16	11.96
Takeda Pharmaceutical	$30.09B	1.58	$712.33M	$0.30	49.88

Is SNY or TAK more profitable?

Sanofi has a net margin of 21.47% compared to Takeda Pharmaceutical's net margin of 3.20%. Sanofi's return on equity of 16.86% beat Takeda Pharmaceutical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanofi	21.47%	16.86%	9.63%
Takeda Pharmaceutical	3.20%	10.50%	5.10%

Is SNY or TAK a better dividend stock?

Sanofi pays an annual dividend of $1.60 per share and has a dividend yield of 3.2%. Takeda Pharmaceutical pays an annual dividend of $0.55 per share and has a dividend yield of 3.7%. Sanofi pays out 38.5% of its earnings in the form of a dividend. Takeda Pharmaceutical pays out 183.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Do insiders and institutionals believe in SNY or TAK?

14.0% of Sanofi shares are held by institutional investors. Comparatively, 9.2% of Takeda Pharmaceutical shares are held by institutional investors. 1.0% of Sanofi shares are held by company insiders. Comparatively, 0.0% of Takeda Pharmaceutical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Does the media prefer SNY or TAK?

In the previous week, Sanofi had 8 more articles in the media than Takeda Pharmaceutical. MarketBeat recorded 14 mentions for Sanofi and 6 mentions for Takeda Pharmaceutical. Sanofi's average media sentiment score of 1.52 beat Takeda Pharmaceutical's score of 0.48 indicating that Sanofi is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sanofi	12 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Takeda Pharmaceutical	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Sanofi beats Takeda Pharmaceutical on 17 of the 19 factors compared between the two stocks.